Stage IVB Squamous Cell Carcinoma of the Oropharynx Completed Phase 2 Trials for Ixabepilone (DB04845)

IndicationStatusPhase
DBCOND0029855 (Stage IVB Squamous Cell Carcinoma of the Oropharynx)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00033618Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and NeckTreatment